Benzinga | Aug 25, 2020 09:45AM EDT

Trinity Biotech Q2 EPS $(0.04) Down From $(0.00) YoY, Sales $16.02M Miss $21.18M Estimate

Trinity Biotech (NASDAQ:TRIB) reported quarterly losses of $(0.04) per share. This is a 1700 percent decrease over losses of $(0.00) per share from the same period last year. The company reported quarterly sales of $16.02 million which missed the analyst consensus estimate of $21.18 million by 24.34 percent. This is a 28.77 percent decrease over sales of $22.50 million the same period last year.